Plain-English translation of NCT07216885 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This clinical trial is testing a new hemodialysis device called the Solv Multi-Pass Hemodialysis System. The study will enroll about 46 patients with kidney failure who currently receive dialysis treatment at dialysis centers. Researchers want to see how well this new system works compared to standard dialysis methods.
Dialysis is a lifesaving treatment for people whose kidneys no longer work, but doctors are always looking for ways to make the treatment more effective and safer. This trial exists to determine whether the Solv Multi-Pass System can improve dialysis outcomes for patients with end-stage kidney disease.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive your regular hemodialysis treatments using the Solv Multi-Pass System at your dialysis center instead of the standard machine. You will continue to visit the center according to your normal dialysis schedule (usually 3 times per week) and undergo routine blood tests and clinical evaluations. The study team will monitor how well the treatment works and watch for any side effects or complications.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
United States